|
Prof. Shai Ashkenazi |
 |
 |
|
Shai Ashkenazi is Professor of Pediatrics at the Sackler Faculty of Medicine, Tel-Aviv University. He is head of pediatric department at Schneider Hospital and a world-renowned expert in infectious diseases. Prof. Ashkenazi participated in clinical development of influenza attenuated vaccine, Shigella conjugate vaccine, RSV passive vaccine and hepatitis A inactivated vaccine.
|
|
|
Dr. Stephen Udem |
|
|
|
Dr. Stephen Udem is an internationally recognized virologist and vaccinologist. He has held senior R&D positions in Wyeth's vaccine division and served as the Senior Vice President of Vaccine Development and Chief Scientific Officer for the International Aids Vaccine Initiative ("IAVI") where he managed the IAVI's vaccine development programs.
|
|
Prof. Mati Fridkin |
|
|
|
Mati Fridkin is Professor of Organic Chemistry at the Weizmann Institute of Science; recognized leader in the field of peptide and protein chemistry, winner of several prestigious awards; has chaired a number of international peptide symposiums; member of the editorial board of a number of important peptide chemistry journals as well as the American Peptide Society, the European Peptide Society, and other professional societies.
|
|
Prof. Myron Levin |
|
|
|
Prof. Myron Levin has been the director for the Center of Vaccine Development at Maryland University since its inception. He is a world-renowned expert in epidemiology, preventive medicine, microbiology, and immunology and developed the attenuated live oral Salmonella typhi vaccine and the Haemophilus influenzae type b vaccine. He is senior editor of New Generation Vaccines and has published over 400 peer-reviewed journal articles. He was the recipient of the Albert B. Sabin Gold Medal Award for lifetime achievement in the area of vaccine development and implementation.
|
|
Dr. Irit Pinchasi |
|
|
|
Dr. Irit Pinchasi worked at Teva Phrmaceutical Industries for over 20 years in various positions within the Innovative R&D Division. In her last role she served as the VP for Global Innovative Research and Development.
Dr. Pinchasi holds a Ph.D. in Neuro-Biochemistry from the Tel-Aviv University.
|
|
Prof. Angel Progador |
|
|
|
Angel Progador is Associate Professor at the Department of Microbiology and Immunology, Faculty of Health Sciences, Ben-Gurion University of the Negev.
He is the co-inventor of VacciGuard's anti-West Nile Virus vaccines.
|
|
Prof. Bracha Rager |
|
|
|
Bracha Rager is Professor at the Department of Microbiology and Immunology Ben-Gurion University of the Negev; served as chief scientist of Israel’s Ministry of Health; president of the Israel Society for Microbiology.
She is the co-inventor of VacciGuard's anti-West Nile Virus vaccines.
|
|
Prof. Meir Wilcheck |
|
|
|
Prof. Meir Wilcheck is a world-renowned organic chemist at the Weizmann Institute of Science. He invented the affinity chromatography and its applications in biomedical sciences and bio-recognition and has been recognized for his work and research (Rothschild Prize in Chemistry; the Wolf Foundation Prize for Medicine; the Pierce Prize for Biorecognition Technology, the Israel Prize for Biotechnology, Sarstedt Prize, and International Distinguished Clinical Chemistry Award). He has published more than 400 scientific articles.
|
|
|
|
|
|
|
